Retrospective Study
Copyright ©The Author(s) 2018.
World J Gastrointest Oncol. Nov 15, 2018; 10(11): 410-420
Published online Nov 15, 2018. doi: 10.4251/wjgo.v10.i11.410
Table 2 Disease free survival and overall survival rates (%) at 12, 36, 60, 90, 120 and 180 mo according to tumor localization
All patients (%)RCC (%)
LCC (%)
DFS (mo)Stage IIStage IIIStage IIStage III
1297.998.996.298.096.8
3689.893.983.694.581.9
6087.093.179.491.878.2
9084.992.675.991.376.7
12084.492.075.090.574.4
18082.790.373.290.572.2
OS (mo)
1299.899.3100.099.7100.0
3696.796.295.599.394.4
6092.494.586.297.087.9
9089.594.082.594.486.4
12087.692.778.993.882.9
18086.692.778.992.182.9